Insider · CIK 0001673528
Daniel Faga
ceopresidentofficerdirector
Files at ANAB (ANAPTYSBIO, INC). First filing Jan 6, 2026, latest Mar 27, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $2.8M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANAB: ANAPTYSBIO, INC
ANABOct 9, 2026 · close 45.95
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | ANABsell ANAPTYSBIO, INC | $1.1M 17,679 shares | -3% | +253% from low-15% from high | |
| 45Moderate | ANAPTYSBIO, INC | $639k 14,281 shares | -3% | +254% from low-14% from high | |
| 41Moderate | ANAPTYSBIO, INC | $415k 9,202 shares | -2% | +265% from low-11% from high | |
| 45Moderate | ANAPTYSBIO, INC | $662k 15,309 shares | -3% | +249% from low-15% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | ANAB ANAPTYSBIO, INC | AGrant or award Common Stock | +34,300 | - | - | 513,644 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -510 | $56.61 | $29k | 513,134 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -2,570 | $57.91 | $149k | 510,564 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -3,662 | $58.62 | $215k | 506,902 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -490 | $59.62 | $29k | 506,412 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -550 | $60.63 | $33k | 505,862 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -1,012 | $62.15 | $63k | 504,850 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -2,592 | $63.35 | $164k | 502,258 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -3,155 | $64.19 | $203k | 499,103 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -3,038 | $65.20 | $198k | 496,065 | Mar 27, 2026 |
| Mar 27, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -100 | $65.99 | $6,599 | 495,965 | Mar 27, 2026 |
| Jan 7, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +26,838 | - | - | 493,625 | Jan 9, 2026 |
| Jan 8, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -14,281 | $44.71 | $639k | 479,344 | Jan 9, 2026 |
| Jan 7, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -26,838 | $0.00 | $0 | 80,512 | Jan 9, 2026 |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +17,850 | - | - | 475,989 | Jan 8, 2026 |
| Jan 7, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -9,202 | $45.11 | $415k | 466,787 | Jan 8, 2026 |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -17,850 | $0.00 | $0 | 17,850 | Jan 8, 2026 |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitderivative | +98,600 | $0.00 | $0 | 98,600 | Jan 8, 2026 |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | AGrant or award Stock Option (right to buy)derivative | +133,400 | $0.00 | $0 | 133,400 | Jan 8, 2026 |
| Jan 3, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +34,677 | - | - | 473,448 | Jan 6, 2026 |
| Jan 5, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -15,309 | $43.26 | $662k | 458,139 | Jan 6, 2026 |
| Jan 3, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -34,677 | $0.00 | $0 | 69,355 | Jan 6, 2026 |
| Jan 3, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +34,678 | - | - | 438,036 | Jan 7, 2025 |
| Jan 3, 2025 | ANAB ANAPTYSBIO, INC | FTax withholding Common Stock | -13,033 | $14.60 | $190k | 425,003 | Jan 7, 2025 |
| Jan 6, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +17,850 | - | - | 442,853 | Jan 7, 2025 |
| Jan 6, 2025 | ANAB ANAPTYSBIO, INC | FTax withholding Common Stock | -6,387 | $15.30 | $98k | 436,466 | Jan 7, 2025 |
| Jan 3, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -34,678 | $0.00 | $0 | 104,032 | Jan 7, 2025 |
| Jan 6, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -17,850 | $0.00 | $0 | 35,700 | Jan 7, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitderivative | +107,350 | $0.00 | $0 | 107,350 | Jan 7, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Stock Option (right to buy)derivative | +305,500 | $0.00 | $0 | 305,500 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.